Sysmex Inostics
Biotechnology, 1812 Ashland Ave, Baltimore, Maryland, 21205, United States, 51-200 Employees
Phone Number: +12*********
Who is SYSMEX INOSTICS
Leaders of the Global Liquid Biopsy Revolution As pioneers in blood-based cell-free tumor DNA (ctDNA) mutation detection, Sysmex Inostics has provided custom assays and CLIA-certified lab...
Read More
-
Headquarters: 1812 Ashland Ave, Baltimore, Maryland, 21205, United States
-
Date Founded: 2008
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
-
CEO:
Shinichi Sato
Email
Phone
Industry: Biotechnology
SIC Code: 8731
|
NAICS Code: 541715 |
Show More
Does something look wrong? Fix it. | View contact records from SYSMEX INOSTICS
Sysmex Inostics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Sysmex Inostics
Answer: Sysmex Inostics's headquarters are located at 1812 Ashland Ave, Baltimore, Maryland, 21205, United States
Answer: Sysmex Inostics's phone number is +12*********
Answer: Sysmex Inostics's official website is https://sysmex-inostics.com
Answer: Sysmex Inostics's revenue is $10 Million to $25 Million
Answer: Sysmex Inostics's SIC: 8731
Answer: Sysmex Inostics's NAICS: 541715
Answer: Sysmex Inostics has 51-200 employees
Answer: Sysmex Inostics is in Biotechnology
Answer: Sysmex Inostics contact info: Phone number: +12********* Website: https://sysmex-inostics.com
Answer: Leaders of the Global Liquid Biopsy Revolution As pioneers in blood-based cell-free tumor DNA (ctDNA) mutation detection, Sysmex Inostics has provided custom assays and CLIA-certified lab services to leading BioPharma companies over the last 10 years with the overall goal: to develop therapeutics that extend lives and provide diagnostics to monitor response to therapy, identify targetable resistance alterations, and detect minimal residual disease (MRD). SafeSEQ NGS technology can detect clinically relevant mutations in circulating tumor DNA (ctDNA) with robust detection as low as 0.03% mutant allele frequency (MAF), thus ensuring reliable molecular information for real-time therapy selection as well as monitoring of tumor response from across a broader range of genomic regions.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month